Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

kConFab, Lim, Elgene, Vaillant, François, Wu, Di, Forrest, Natasha C, Pal, Bhupinder, Hart, Adam H, Asselin-Labat, Marie-Liesse +13 more·2009·Nature Medicine
DOI 10.1038/nm.2000

Cited by (1,001)

Items 701–800 of 1,001

  1. Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer
    Montserrat Pérez-Salvia, Laia Simó‐Riudalbas, Pere Llinàs‐Arias, Laura Roa, Fernando Setién, Marta Soler, Manuel Castro de Moura, James E. Bradner, Eva González‐Suárez, Cátia Moutinho et al. · 2017 · Oncotarget
  2. Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells
    Lynsey M. Fettig, Olivia McGinn, Jessica Finlay-Schultz, Daniel V. LaBarbera, Steven K. Nordeen, Carol A. Sartorius · 2017 · Oncogene
  3. Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action
    Kathleen A. O’Leary, Michael P. Shea, Stephanie Salituro, Courtney E. Blohm, Linda A. Schuler · 2017 · Stem Cell Reports
  4. Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era
    Gabriel S. Macedo, Bárbara Alemar, Patrícia Ashton‐Prolla · 2019 · Genetics and Molecular Biology
  5. Combined Bcl-2/Src inhibition synergize to deplete stem-like breast cancer cells
    Qi Sun, Yu‐Fen Wang, Jay S. Desgrosellier · 2019 · Cancer Letters
  6. The Role of BRCA1/2-Mutated Tumor Microenvironment in Breast Cancer
    Svetlana Miklikova, Lenka Trnkova, Jana Plavá, Martin Boháč, Marcela Kuniaková, Marina Cihova · 2021 · Cancers
  7. A Long-Lived Luminal Subpopulation Enriched with Alveolar Progenitors Serves as Cellular Origin of Heterogeneous Mammary Tumors
    Luwei Tao, Maaike P.A. van Bragt, Zhe Li · 2015 · Stem Cell Reports
  8. The Significance and Therapeutic Potential of GATA3 Expression and Mutation in Breast Cancer: A Systematic Review
    Feng Du, Peng Yuan, Teng Wang, Jiuda Zhao, Zitong Zhao, Yang Luo, Binghe Xu · 2015 · Medicinal Research Reviews
  9. Increased macroH2A1.1 Expression Correlates with Poor Survival of Triple-Negative Breast Cancer Patients
    Anne-Claire Lavigne, Magali Castells, Jérôme Mermet, Silvia Kocanova, Mathieu Dalvai, Kerstin Bystricky · 2014 · PLoS ONE
  10. Does Microenvironment Contribute to the Etiology of Estrogen Receptor–Negative Breast Cancer?
    Mary Helen Barcellos‐Hoff · 2013 · Clinical Cancer Research
  11. Paracrine Met signaling triggers epithelial–mesenchymal transition in mammary luminal progenitors, affecting their fate
    Amandine Di-Cicco, Valérie Petit, Aurélie Chiche, Laura Bresson, Mathilde Romagnoli, Véronique Orian‐Rousseau, María dM Vivanco, Daniel Medina, Marisa M. Faraldo, Marina A. Glukhova et al. · 2015 · eLife
  12. Gene-expression data integration to squamous cell lung cancer subtypes reveals drug sensitivity
    Wu, D, Pang, Y, Wilkerson, M D, Wang, D, Hammerman, P S, Liu, J S · 2013 · British Journal of Cancer
  13. Ductal barriers in mammary epithelium
    Mark B. Owens, Arnold D. K. Hill, Ann M. Hopkins · 2013 · Tissue Barriers
  14. kConFab: A Familial Breast Cancer Consortium Facilitating Research and Translational Oncology
    Heather Thorne, Gillian Mitchell, Stephen B. Fox · 2011 · JNCI Monographs
  15. Microenvironment-Induced Non-sporadic Expression of the AXL and cKIT Receptors Are Related to Epithelial Plasticity and Drug Resistance
    Tiina A. Jokela, Agnete S. T. Engelsen, Agata Marta Rybicka, Fanny A. Pelissier Vatter, James C. Garbe, Masaru Miyano, Crina Elena Tiron, Dan Ferariu, Lars A. Akslen, Martha R. Stampfer et al. · 2018 · Frontiers in Cell and Developmental Biology
  16. Stathmin expression associates with vascular and immune responses in aggressive breast cancer subgroups
    Cecilie Askeland, Elisabeth Wik, Kenneth Finne, Even Birkeland, Jarle B. Arnes, Karin Collett, Gøril Knutsvik, Kristi Krüger, Benedicte Davidsen, Turid Aas et al. · 2020 · Scientific Reports
  17. PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
    Feng Bai, Shiqin Liu, Xiong Liu, Daniel P. Hollern, Alexandria Scott, Chuying Wang, Lihan Zhang, Cheng Fan, Li Fu, Charles M. Perou et al. · 2021 · Breast Cancer Research
  18. Loss of function of GATA3 induces basal-like mammary tumors
    Feng Bai, Chenglong Zheng, Xiong Liu, Ho Lam Chan, Shiqin Liu, Jinshan Ma, Sijia Ren, Wei‐Guo Zhu, Xin‐Hai Pei · 2021 · Theranostics
  19. 2-Hydroxyglutarate destabilizes chromatin regulatory landscape and lineage fidelity to promote cellular heterogeneity
    Meena Kusi, Maryam Zand, Li‐Ling Lin, Meizhen Chen, Anthony Lopez, Chun-Lin Lin, Chiou‐Miin Wang, Nicholas L. L. Lucio, Nameer B. Kirma, Jianhua Ruan et al. · 2022 · Cell Reports
  20. Loss of SNAI1 induces cellular plasticity in invasive triple-negative breast cancer cells
    Chrysoula Tsirigoti, Mohamad Moustafa Ali, Varun Maturi, Carl‐Henrik Heldin, Aristidis Moustakas · 2022 · Cell Death and Disease
  21. Challenges in the development of future treatments for breast cancer stem cells
    Patel · 2010 · Breast Cancer Targets and Therapy
  22. Challenges to Developing Proteomic-Based Breast Cancer Diagnostics
    Richard R. Drake, Lisa H. Cazares, Elizabeth Ellen Jones, Thomas W. Fuller, Oliver John Semmes, Christine Laronga · 2011 · OMICS A Journal of Integrative Biology
  23. Combining Notch inhibition with current therapies for breast cancer treatment
    Keith R. Brennan, Robert B. Clarke · 2012 · Therapeutic Advances in Medical Oncology
  24. The classification of invasive carcinoma of the breast
    Louisa M Gannon, Maura B. Cotter, Cecily Quinn · 2013 · Expert Review of Anticancer Therapy
  25. Revealing the Molecular Portrait of Triple Negative Breast Tumors in an Understudied Population through Omics Analysis of Formalin-Fixed and Paraffin-Embedded Tissues
    Felipe Vaca‐Paniagua, Rosa María Álvarez-Gómez, Héctor Aquiles Maldonado-Martínez, Carlos Pérez‐Plasencia, Verónica Fragoso‐Ontiveros, Federico Lasa-Gonsebatt, Luis A. Herrera, David Francisco Cantú de León, Enrique Bargalló‐Rocha, Alejandro Mohar et al. · 2015 · PLoS ONE
  26. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development
    Arusha Oloumi, Mykola M. Maidan, Frances E. Lock, Howard Tearle, Steven E. McKinney, William J. Muller, Samuel A. J. R. Aparicio, Shoukat Dedhar · 2010 · Breast Cancer Research
  27. Matrix metalloproteinase function in non-mammalian model organisms
    Jason R. Jessen · 2011 · Frontiers in Bioscience-Scholar
  28. Mammary-specific ablation of Cyp24a1 inhibits development, reduces proliferation and increases sensitivity to vitamin D
    Lei Sheng, Andrew G. Turner, Kate R. Barratt, Richard B. Kremer, Howard A. Morris, David Frederick Callen, Paul Anderson, Gerard A. Tarulli · 2019 · The Journal of Steroid Biochemistry and Molecular Biology
  29. Laminin-binding integrins are essential for the maintenance of functional mammary secretory epithelium in lactation
    Mathilde Romagnoli, Laura Bresson, Amandine Di-Cicco, María Pérez-Lanzón, Patricia Legoix, Sylvain Baulande, Pierre de la Grange, Adèle De Arcangelis, Elisabeth Georges‐Labouesse, Arnoud Sonnenberg et al. · 2020 · Development
  30. Regulation of a progenitor gene program by SOX4 is essential for mammary tumor proliferation
    M. Guy Roukens, Cynthia Lisanne Frederiks, Daniëlle Seinstra, Luca Braccioli, Antoine A Khalil, Cornelieke E. G. M. Pals, Simon De Neck, Laura Bornes, Evelyne Beerling, Michal Mokrý et al. · 2021 · Oncogene
  31. Tumour Stem Cells in Breast Cancer
    Marina Konstantinovna Ibragimova, Matvey Mikhailovich Tsyganov, Николай Васильевич Литвяков · 2022 · International Journal of Molecular Sciences
  32. Mammary gland stem cells: current status and future challenges
    Agla J. Fridriksdottir, OLE WILLIAM PETERSEN, Lone Rønnov‐Jessen · 2011 · The International Journal of Developmental Biology
  33. Keeping an open mind: highlights and controversies of the breast cancer stem cell theory
    Cinzia Allegrucci, Mansi Shah · 2012 · Breast Cancer Targets and Therapy
  34. p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors
    Aurélie Chiche, Mejdi Moumen, Mathilde Romagnoli, Valérie Petit, Hamza Lasla, Pascal Jézéquel, Pierre de la Grange, Jos Jonkers, Marie‐Ange Deugnier, Marina A. Glukhova et al. · 2016 · Oncogene
  35. Targeting the PyMT Oncogene to Diverse Mammary Cell Populations Enhances Tumor Heterogeneity and Generates Rare Breast Cancer Subtypes
    B. A. Smith, Dawne N. Shelton, Collin Kieffer, Brett A. Milash, Jerry Usary, Charles M. Perou, Philip Seth Bernard, Bryan E. Welm · 2012 · Genes & Cancer
  36. Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications
    Vida Pourteimoor, Samira Mohammadi‐Yeganeh, Mahdi Paryan · 2016 · Tumor Biology
  37. Progesterone Exposure and Breast Cancer Risk
    Purna A. Joshi, Pamela Jean Goodwin, Rama Khokha · 2015 · JAMA Oncology
  38. ERG-driven prostate cancer initiation is cell-context dependent and requires KMT2A and DOT1L
    Weiran Feng, Erik Ladewig, Matthew Lange, Nazifa Salsabeel, HuiYong Zhao, Young Sun Lee, Anuradha Gopalan, Hanzhi Luo, Wenfei Kang, Ning Fan et al. · 2025 · Nature Genetics
  39. Studying Therapy Response and Resistance in Mouse Models for BRCA1-Deficient Breast Cancer
    Ewa Malgorzata Michalak, Jos Jonkers · 2011 · Journal of Mammary Gland Biology and Neoplasia
  40. Breast Cancer and Cancer Stem Cells: A Mini-Review
    Alžběta Filipová, Martina Seifrtová, Jaroslav Mokrý, Josef Dvořák, Martina Řezáčová, Stanislav Filip, Daniel Diaz Garcia · 2014 · Tumori Journal
  41. Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor β
    Yuko Murakami-Nishimagi, Kotaro Sugimoto, Makoto Kobayashi, Kazunoshin Tachibana, Manabu Kojima, Maiko Okano, Yuko Hashimoto, Shigehira Saji, Tohru Ohtake, Hideki Chiba · 2023 · Breast Cancer Research
  42. Crosstalk of the Insulin-Like Growth Factor Receptor with the Wnt Signaling Pathway in Breast Cancer
    Lauren M. Rota, Teresa L. Wood · 2015 · Frontiers in Endocrinology
  43. Somatic Expression of PyMT or Activated ErbB2 Induces Estrogen-Independent Mammary Tumorigenesis
    Michael Joseph Toneff, Zhijun Du, Jie Dong, Jian Huang, Parisa Sinai, James Forman, Susan Galloway Hilsenbeck, Rachel Schiff, Shixia Huang, Yi Li · 2010 · Neoplasia
  44. The Gene Desert Mammary Carcinoma Susceptibility Locus Mcs1a Regulates Nr2f1 Modifying Mammary Epithelial Cell Differentiation and Proliferation
    Bart M. G. Smits, Jill D. Haag, Anna I. Rissman, Deepak Sharma, Ann Tran, Alexi A. Schoenborn, Rachael C. Baird, Daniel S. Peiffer, David Q. Leinweber, Matthew J. Muelbl et al. · 2013 · PLoS Genetics
  45. Notch-1 signaling promotes the cyclinD1-dependent generation of mammary tumor-initiating cells that can revert to bi-potential progenitors from which they arise
    H Ling, Paul Jolicoeur · 2012 · Oncogene
  46. Estimating the proportion of microarray probes expressed in an RNA sample
    Wei Shi, Carolyn A. de Graaf, Sarah Kinkel, Ariel H. Achtman, Tracey M. Baldwin, Louis Schofield, Hamish S. Scott, Douglas J. Hilton, Gordon K. Smyth · 2010 · Nucleic Acids Research
  47. Undifferentiated State Induced by Rb-p53 Double Inactivation in Mouse Thyroid Neuroendocrine Cells and Embryonic Fibroblasts
    Shunsuke Kitajima, Susumu Kohno, Atsushi Kondoh, Nobunari Sasaki, Yuuki Nishimoto, Fengkai Li, Mohammed Salah Abdallah Mohammed, Hayato Muranaka, Naoko Nagatani, Misa Suzuki et al. · 2015 · Stem Cells
  48. Linear Models for Microarray and RNA-Seq Data User's Guide
    Gordon K. Smyth, Matthew E. Ritchie, Natalie Thorne, James M. Wettenhall, Wei Shi, Yifang Hu · 2015
  49. Genetic suppression reveals DNA repair-independent antagonism between BRCA1 and COBRA1 in mammary gland development
    Sreejith J. Nair, Xiaowen Zhang, Huai-Chin Chiang, Md Jamiul Jahid, Yao Wang, Paula Garza, Craig April, Neeraj S. Salathia, Tapahsama Banerjee, Fahaad Alenazi et al. · 2016 · Nature Communications
  50. Functional Purification of Human and Mouse Mammary Stem Cells
    Daniela Tosoni, Pier Paolo Di Fiore, Salvatore Pece · 2012 · Methods in molecular biology
  51. Oestrogen receptor negativity in breast cancer: a cause or consequence?
    Vijaya Narasihma Reddy Gajulapalli, Vijaya Lakshmi Malisetty, Suresh Kumar Chitta, Bramanandam Manavathi · 2016 · Bioscience Reports
  52. BRCA1-Dependent Transcriptional Regulation: Implication in Tissue-Specific Tumor Suppression
    Xiaowen Zhang, Rong Li · 2018 · Cancers
  53. BRCA1 and BRCA2: a common pathway of genome protection but different breast cancer subtypes
    Simon Andreas Joosse · 2012 · Nature reviews. Cancer
  54. Conditional Knockout Mouse Models of Cancer
    Chu‐Xia Deng · 2014 · Cold Spring Harbor Protocols
  55. Tumor mutational landscape is a record of the pre-malignant state
    Kirsten Kübler, Rosa Karlić, Nicholas J. Haradhvala, Kyungsik Ha, Jaegil Kim, Maja Kuzman, Wei Jiao, Sitanshu Gakkhar, Kent William Mouw, Lior Zvi Braunstein et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  56. A stratification system for breast cancer based on basoluminal tumor cells and spatial tumor architecture
    Lasse Meyer, Hartland Warren Jackson, Nils Eling, Shan Zhao, Genki Usui, Haithem Dakhli, Peter Schraml, Susanne Dettwiler, Constanze Elfgen, Zsuzsanna Varga et al. · 2025 · Cancer Cell
  57. Cancer du sein triple-négatif : caractéristiques histocliniques et moléculaires, prise en charge et perspectives thérapeutiques
    Anthony Gonçalvès, Renaud Sabatier, Emmanuelle Charafe‐Jauffret, Marine Gilabert, Magali Provansal, Carole Tarpin, Jean-Marc Extra, Patrice Viens, François Bertucci · 2013 · Bulletin du Cancer
  58. Multifunctional Proteins Bridge Mitosis with Motility and Cancer with Inflammation and Arthritis
    Jihong Jiang, Rosaely Casalegno‐Garduño, Helen Chen, Anita Schmitt, Michael W. Schmitt, Christopher A. Maxwell · 2010 · The Scientific World JOURNAL
  59. Differentiation Generates Paracrine Cell Pairs That Maintain Basaloid Mouse Mammary Tumors: Proof of Concept
    Soyoung Kim, Shruti Goel, Caroline M. Alexander · 2011 · PLoS ONE
  60. BRCA1 Haploinsufficiency Leads to Altered Expression of Genes Involved in Cellular Proliferation and Development
    Harriet E. Feilotter, Claire S. Michel, Paolo Uy, Lauren Bathurst, Scott K. Davey · 2014 · PLoS ONE
  61. A MYC-ZNF148-ID1/3 regulatory axis modulating cancer stem cell traits in aggressive breast cancer
    Mijeong Kim, Manjot Singh, Bum‐Kyu Lee, Moira E. Hibbs, Kirsty L. Richardson, Lesley G. Ellies, Larissa C. Wintle, Lisa M. Stuart, Jenny Yingzi Wang, Dominic Chih‐Cheng Voon et al. · 2022 · Oncogenesis
  62. Axes of differentiation in breast cancer: untangling stemness, lineage identity, and the epithelial to mesenchymal transition
    Roy Zvi Granit, Michal Slyper, Ittai Ben‐Porath · 2013 · WIREs Systems Biology and Medicine
  63. Statistical Association of Basal Cell Keratins with Metastasis-Inducing Proteins in a Prognostically Unfavorable Group of Sporadic Breast Cancers
    Suzete de Silva Rudland, Angela M. Platt-Higgins, John H. R. Winstanley, Nigel J. Jones, Roger Barraclough, Christopher R. West, Joseph Carroll, Philip S. Rudland · 2011 · American Journal Of Pathology
  64. EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells
    Ólafur Andri Stefánsson, Manel Esteller · 2011 · Breast Cancer Research
  65. Current Progresses of Single Cell DNA Sequencing in Breast Cancer Research
    Jianlin Liu, Ragini Adhav, Xiaoling Xu · 2017 · International Journal of Biological Sciences
  66. Pharmacological targets of breast cancer stem cells: a review
    Sai Kiran S. S. Pindiprolu, Praveen Thaggikuppe Krishnamurthy, Pavan Kumar Chintamaneni · 2018 · Naunyn-Schmiedeberg s Archives of Pharmacology
  67. p53 controls the plasticity of mammary luminal progenitor cells downstream of Met signaling
    Aurélie Chiche, Amandine Di-Cicco, Laura Sesma-Sanz, Laura Bresson, Pierre de la Grange, Marina A. Glukhova, Marisa M. Faraldo, Marie‐Ange Deugnier · 2019 · Breast Cancer Research
  68. BRCA1 mutations attenuate super-enhancer function and chromatin looping in haploinsufficient human breast epithelial cells
    Xiaowen Zhang, Yao Wang, Huai-Chin Chiang, Yuan-Pang Hsieh, Chang Lu, Ben Ho Park, Ismail Jatoi, Victor X. Jin, Yanfen Hu, Rong Li · 2019 · Breast Cancer Research
  69. A new view of the mammary epithelial hierarchy and its implications for breast cancer initiation and metastasis
    Lindsey J. Anstine, Ruth A. Keri · 2019 · Journal of Cancer Metastasis and Treatment
  70. MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancer
    Michael J. G. Milevskiy, Gurveen Kaur Sandhu, Anna Wronski, Darren J. Korbie, Brooke L. Brewster, Annette M. Shewan, Stacey L. Edwards, Juliet D. French, Melissa A. Brown · 2018 · Oncotarget
  71. BRCA1 mutation influences progesterone response in human benign mammary organoids
    Batzaya Davaadelger, Mi-Ran Choi, Hari Singhal, Susan E. Clare, Seema Ahsan Khan, Julie J. Kim · 2019 · Breast Cancer Research
  72. Distinct clinicopathological features and treatment differences in breast cancer patients of young age
    Rasmus O. C. Humlevik, Amalie A. Svanøe, Turid Aas, Anette Heie, Anna Kristine Myrmel Sæle, Lars A. Akslen, Elisabeth Wik, Erling André Høivik · 2025 · Scientific Reports
  73. SOX factors as cell-state regulators in the mammary gland and breast cancer
    Yu Liu, Wenjun Guo · 2021 · Seminars in Cell and Developmental Biology
  74. Stem-like breast cancer cells in the activated state resist genetic stress via TGFBI-ZEB1
    Qi Sun, Yu‐Fen Wang, Adam Officer, Brianna Pecknold, Garrett Lee, Olivier Harismendy, Jay S. Desgrosellier · 2022 · npj Breast Cancer
  75. COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis
    Janelle L. Hancock, Murugan Kalimutho, Jasmin Straube, Malcolm Lim, Irma L. Gresshoff, Jodi M. Saunus, Jason S. Lee, Sunil R. Lakhani, Kaylene J. Simpson, Ashley Ian Bush et al. · 2023 · Journal of Experimental & Clinical Cancer Research
  76. Epithelial to mesenchymal transition as a portal to stem cell characters embedded in gene networks
    Naisana S. Asli, Richard Paul Harvey · 2012 · BioEssays
  77. The biology of human breast epithelial progenitors
    Afshin Raouf, Yujia Sun, Sumanta Chatterjee, Pratima Basak · 2012 · Seminars in Cell and Developmental Biology
  78. Distinct claudin expression characterizes BRCA 1‐related breast cancer
    Marise R. Heerma van Voss, P. J. van Diest, Yvonne H. C. M. Smolders, Joost Bart, Elsken van der Wall, Petra van der Groep · 2014 · Histopathology
  79. ΔNp63α induces quiescence and downregulates the BRCA1 pathway in estrogen receptor‐positive luminal breast cancer cell line MCF7 but not in other breast cancer cell lines
    Ruhul Amin, Yuiko Morita‐Fujimura, Hiroshi Tawarayama, Kentaro Semba, Natsuko Chiba, Manabu Fukumoto, Shuntaro Ikawa · 2015 · Molecular Oncology
  80. New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem Cells
    Carmel O’Brien, Hun S. Chy, Qi Zhou, Shiri Blumenfeld, Jack Lambshead, Xiaodong Liu, Joshua Kie, Bianca D. Capaldo, Tung-Liang Chung, Timothy E. Adams et al. · 2016 · Stem Cells
  81. Single-cell evaluation reveals shifts in the tumor-immune niches that shape and maintain aggressive lesions in the breast
    Vidya C. Sinha, Amanda L. Rinkenbaugh, Mingchu Xu, Xinhui Zhou, Xiaomei Zhang, Sabrina L. Jeter-Jones, Jiansu Shao, Yuan Qi, John A. Zebala, Dean Y. Maeda et al. · 2021 · Nature Communications
  82. Mesenchymal precursor cells maintain the differentiation and proliferation potentials of breast epithelial cells
    Stephan Duss, Heike Brinkhaus, Adrian Britschgi, Erik Cabuy, Daniel M. Frey, Dirk J. Schaefer, Mohamed Bentires‐Alj · 2014 · Breast Cancer Research
  83. Somatic genetic aberrations in benign breast disease and the risk of subsequent breast cancer
    Zexian Zeng, Andy H. Vo, Xiaoyu Li, Ali Shidfar, Paulette Saldana, Luis Z. Blanco, Xiaoling Xuei, Yuan Luo, Seema Ahsan Khan, Susan E. Clare · 2020 · npj Breast Cancer
  84. Pathogenic BRCA1 variants disrupt PLK1-regulation of mitotic spindle orientation
    Zhengcheng He, Ryan Ghorayeb, Susanna Tan, Ke Chen, Amanda C. Lorentzian, Jack Bottyan, Syed Mohammed Musheer Aalam, Miguel Ángel Pujana, Philipp F. Lange, Nagarajan Kannan et al. · 2022 · Nature Communications
  85. Ductal keratin 15+ luminal progenitors in normal breast exhibit a basal-like breast cancer transcriptomic signature
    Katharina Theresa Kohler, Nadine Goldhammer, Samuel Demharter, Ulrich Pfisterer, Konstantin V. Khodosevich, Lone Rønnov‐Jessen, OLE WILLIAM PETERSEN, René Villadsen, Jiyoung Kim · 2022 · npj Breast Cancer
  86. Clinical applications of 3D normal and breast cancer organoids: A review of concepts and methods
    Steven M. Lewis, Mackenzie K. Callaway, Camila O. dos Santos · 2022 · Experimental Biology and Medicine
  87. Overexpression of Id1 in transgenic mice promotes mammary basal stem cell activity and breast tumorigenesis
    Dong‐Hui Shin, Ji‐Hye Park, Jeong‐Yeon Lee, Hee‐Young Won, Ki-Seok Jang, Kyueng‐Whan Min, Si‐Hyong Jang, Jong Kyu Woo, Seung Hyun Oh, Gu Kong · 2015 · Oncotarget
  88. Ecosystems of invasion and metastasis in mammary morphogenesis and cancer
    Marc Mareel, Susana Constantino Rosa Santos · 2011 · The International Journal of Developmental Biology
  89. Novel role of microRNA146b in promoting mammary alveolar progenitor cell maintenance
    Hanan S. Elsarraj, Yan Hong, Kelli Elizabeth Valdez, Martha Z. Carletti, Sally M. Salah, Monica Raimo, Daniela Taverna, Philippe Prochasson, Uddalak Bharadwaj, David John Tweardy et al. · 2013 · Journal of Cell Science
  90. Decreased expression of BRCA1 in SK-BR-3 cells is the result of aberrant activation of the GABP Beta promoter by an NRF-1-containing complex
    Crista Thompson, Gwen MacDonald, Christopher R. Mueller · 2011 · Molecular Cancer
  91. CK8/18 expression, the basal phenotype, and family history in identifying BRCA1‐associated breast cancer in the Ontario site of the Breast Cancer Family Registry
    Anna Marie Mulligan, Dushanthi Pinnaduwage, Anita L. Bane, Shelley B. Bull, Frances P. O’Malley, Irene Louise Andrulis · 2010 · Cancer
  92. Reversible interconversion and maintenance of mammary epithelial cell characteristics by the ligand-regulated EGFR system
    Shinji Fukuda, Hisayo Nishida‐Fukuda, Daisuke Nanba, Koh‐ichi Nakashiro, Hironao Nakayama, Hiroyuki Kubota, Shigeki Higashiyama · 2016 · Scientific Reports
  93. ‘Normalizing’ the malignant phenotype of luminal breast cancer cells via alpha(v)beta(3)-integrin
    Hanan Abu-Tayeh, Keren Weidenfeld, Alisa Zhilin-Roth, Sagie Schif‐Zuck, Sonja Thaler, Cristina Cotarelo, Tuan Zea Tan, Jean Paul Thiery, Jeffrey E. Green, Geula Klorin et al. · 2016 · Cell Death and Disease
  94. An essential role of CBL and CBL-B ubiquitin ligases in mammary stem cell maintenance
    Bhopal C. Mohapatra, Neha Zutshi, Wei An, Benjamin T. Goetz, Priyanka Arya, Timothy Alan Bielecki, Insha Mushtaq, Matthew D. Storck, Jane L. Meza, Vimla Band et al. · 2017 · Development
  95. The Wnt Signaling Landscape of Mammary Stem Cells and Breast Tumors
    Caroline M. Alexander · 2017 · Progress in molecular biology and translational science
  96. Targeting Obesity-Induced Macrophages during Preneoplastic Growth Promotes Mammary Epithelial Stem/Progenitor Activity, DNA Damage, and Tumor Formation
    Tamara Chamberlin, Megan Clack, Caylee Silvers, Genevra M. Kuziel, Victoria Thompson, Haley E. Johnson, Lisa M. Arendt · 2020 · Cancer Research
  97. The Antiproliferative Effects of Progestins in T47D Breast Cancer Cells Are Tempered by Progestin Induction of the ETS Transcription Factor Elf5
    Heidi N. Hilton, Maria Kalyuga, Mark J. Cowley, M. Chehani Alles, Heather J Lee, Catherine Elizabeth Caldon, Katrina D. Blazek, Warren H. Kaplan, Elizabeth A. Musgrove, Roger J. Daly et al. · 2010 · Molecular Endocrinology
  98. A Marker of Endocrine Receptor-Positive Cells, CEACAM6, Is Shared by Two Major Classes of Breast Cancer
    Emilie Balk-Møller, Jiyoung Kim, Branden Michael Hopkinson, Vera Timmermans Wielenga, OLE WILLIAM PETERSEN, René Villadsen · 2014 · American Journal Of Pathology
  99. Correction: In Vitro Analysis of Breast Cancer Cell Line Tumourspheres and Primary Human Breast Epithelia Mammospheres Demonstrates Inter- and Intrasphere Heterogeneity
    Chanel Elisha Smart, Brian J. Morrison, Jodi M. Saunus, Ana Cristina Vargas, Patricia Keith, Lynne Reid, Leesa F. Wockner, Marjan Askarian-Amiri, Debina Sarkar, Peter T. Simpson et al. · 2013 · PLoS ONE
  100. Single-cell integrative analysis reveals consensus cancer cell states and clinical relevance in breast cancer
    Lin Pang, Fengyu Xiang, Huan Min Yang, Xinyue Shen, Ming Fang, Ran Li, Yongjin Long, Jiali Li, Yonghuan Yu, Bo Pang · 2024 · Scientific Data